Literature DB >> 9263327

Biological role of tyrosinase related protein and its biosynthesis and transport from TGN to stage I melanosome, late endosome, through gene transfection study.

K Jimbow1, P F Gomez, K Toyofuku, D Chang, S Miura, H Tsujiya, J S Park.   

Abstract

Tyrosinase-related protein (TRP)-1 is one of the most abundant melanosomal glycoproteins involved in melanogenesis. This report summarizes our recent research efforts related to the biological role and biosynthesis of TRP-1 and its transport from TGN (trans-Golgi network) to the stage I melanosome. Our UV irradiation and tyrosinase and TRP-1 cDNA co-transfection studies indicated that human TRP-1 is involved in not only melanogenesis but also prevention of melanocyte death, which may occur during biosynthesis of melanin pigment in the presence of tyrosinase. Furthermore, a coordinated gene interaction was indicated between tyrosinase and TRP-1, resulting in upregulation of mRNA and protein expression of LAMP (lysosome-associated membrane protein)-1 that would directly prevent the tyrosinase-mediated programmed cell death of melanocytes. Similar to tyrosinase, however, TRP-1 appears to require a molecular chaperone, calnexin, which we have cloned recently. Our cDNA transfection study of tyrosinase with calnexin showed clearly the necessity of calnexin in order to have efficient, functional activity of melanosomal glycoprotein, especially tyrosinase. Once glycosylation is completed, TRP-1 will be transported from TGN to the stage I melanosome. At this stage, TRP-1 will have its own target signal, in particular, tyrosine-rich leucine residues in cytoplasmic tail. Our TRP-1 cDNA transfection and immunoelectron microscopy study shows that TRP-1 will be transported through small vesicles, probably non-clathrin-coated type, to large vacuoles, identical to the MPR (mannose-6-phosphate receptor)-positive, late endosomes. In this transport process a low molecular weight G-protein, rab-7, was isolated from the purified melanosomal protein on 2D-PAGE and identified by subsequent sequencing and PCR amplification. Confocal microscopy with double immunostaining and immunoelectron microscopy confirmed the co-localization of rab-7 and TRP-1 in the melanosomes with early stages of maturation (I-HI). Furthermore, this process will also be regulated by phosphatidylinositol 3-kinase (PI-3 kinase).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9263327     DOI: 10.1111/j.1600-0749.1997.tb00486.x

Source DB:  PubMed          Journal:  Pigment Cell Res        ISSN: 0893-5785


  10 in total

1.  A new continuous spectrophotometric assay method for DOPA oxidase activity of tyrosinase.

Authors:  Yong-Doo Park; Jae-Rin Lee; Kyung-Hee Park; Hwa-Sun Hahn; Myong-Joon Hahn; Jun-Mo Yang
Journal:  J Protein Chem       Date:  2003-07

2.  Classical autophagy proteins LC3B and ATG4B facilitate melanosome movement on cytoskeletal tracks.

Authors:  Amrita Ramkumar; Divya Murthy; Desingu Ayyappa Raja; Archana Singh; Anusha Krishnan; Sangeeta Khanna; Archana Vats; Lipi Thukral; Pushkar Sharma; Sridhar Sivasubbu; Rajni Rani; Vivek T Natarajan; Rajesh S Gokhale
Journal:  Autophagy       Date:  2017-06-09       Impact factor: 16.016

Review 3.  Autoimmunity and the immunotherapy of cancer: targeting the "self" to destroy the "other".

Authors:  W W Overwijk; N P Restifo
Journal:  Crit Rev Immunol       Date:  2000       Impact factor: 2.214

4.  Melanophilin, the product of the leaden locus, is required for targeting of myosin-Va to melanosomes.

Authors:  D William Provance; Ted L James; John A Mercer
Journal:  Traffic       Date:  2002-02       Impact factor: 6.215

Review 5.  Tyrosinase related protein 1 (TYRP1/gp75) in human cutaneous melanoma.

Authors:  Ghanem Ghanem; Journé Fabrice
Journal:  Mol Oncol       Date:  2011-02-03       Impact factor: 6.603

6.  Characterization of genes modulated during pheomelanogenesis using differential display.

Authors:  M Furumura; C Sakai; S B Potterf; W D Vieira; G S Barsh; V J Hearing
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

7.  Melanoma-Targeted Chemothermotherapy and In Situ Peptide Immunotherapy through HSP Production by Using Melanogenesis Substrate, NPrCAP, and Magnetite Nanoparticles.

Authors:  Kowichi Jimbow; Yasue Ishii-Osai; Shosuke Ito; Yasuaki Tamura; Akira Ito; Akihiro Yoneta; Takafumi Kamiya; Toshiharu Yamashita; Hiroyuki Honda; Kazumasa Wakamatsu; Katsutoshi Murase; Satoshi Nohara; Eiichi Nakayama; Takeo Hasegawa; Itsuo Yamamoto; Takeshi Kobayashi
Journal:  J Skin Cancer       Date:  2013-02-21

8.  TYRP1 mRNA expression in melanoma metastases correlates with clinical outcome.

Authors:  F Journe; H Id Boufker; L Van Kempen; M-D Galibert; M Wiedig; F Salès; A Theunis; D Nonclercq; A Frau; G Laurent; A Awada; G Ghanem
Journal:  Br J Cancer       Date:  2011-11-01       Impact factor: 7.640

Review 9.  Pharmacologic manipulation of skin pigmentation.

Authors:  Gabriel H Kindl; John A D'Orazio
Journal:  Pigment Cell Melanoma Res       Date:  2021-03-12       Impact factor: 4.159

10.  Glycosphingolipids are required for sorting melanosomal proteins in the Golgi complex.

Authors:  H Sprong; S Degroote; T Claessens; J van Drunen; V Oorschot; B H Westerink; Y Hirabayashi; J Klumperman; P van der Sluijs; G van Meer
Journal:  J Cell Biol       Date:  2001-10-22       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.